Notice: file_put_contents(): Write of 10335 bytes failed with errno=28 No space left on device in /var/www/tg-me/post.php on line 50
Readhub | Telegram Webview: readhub_cn/252895 -
Telegram Group & Telegram Channel
北京市明确未来产业新航向 中国药谷布局5大赛道引领生命健康产业高质量发展

北京大兴生物医药产业基地聚焦五大未来产业,包括基因技术、细胞治疗与再生医学、脑科学与脑机接口、合成生物及生物医用材料,通过全产业链布局和技术突破,推动生命健康产业集群发展。基地已形成覆盖基因治疗、细胞治疗、脑科学、合成生物和高端生物医用材料的产业生态,吸引多家领先企业入驻,助力首都生命健康产业高质量发展。

媒体报道
洞见 I 中国创新药,下一个10年怎么投? 医药魔方
创新药板块强势表现吸引市场关注,恒生创新药ETF(520500)连续六周获资金净流入 新浪科技
北京市明确未来产业新航向 中国药谷布局5大赛道引领生命健康产业高质量发展 医药魔方
年销8亿的抗精神药,国内已有4家仿制获批 医药魔方
26家创新药公司完成新一轮融资! 医药魔方
31家药企厮杀18亿畅销药!第十一批国采110+品种达入场线... 医药魔方
11款抗肿瘤新药有望第二季度获批上市 医药魔方

事件追踪
2025-01-14 北京:重点培育人形机器人、商业航天、生物制造、新材料等20个未来产业
2025-01-09 北京力推脑机接口创新,2030年或实现多领域规模化商用
2025-01-09 北京出台《加快脑机接口创新发展行动方案(2025-2030年)》
2024-05-23 北京:到2026年 医药健康产业总规模达到1.25万亿元
2023-06-28 北京市政府办公厅印发《北京市机器人产业创新发展行动方案(2023—2025年)》

#热门话题



tg-me.com/readhub_cn/252895
Create:
Last Update:

北京市明确未来产业新航向 中国药谷布局5大赛道引领生命健康产业高质量发展

北京大兴生物医药产业基地聚焦五大未来产业,包括基因技术、细胞治疗与再生医学、脑科学与脑机接口、合成生物及生物医用材料,通过全产业链布局和技术突破,推动生命健康产业集群发展。基地已形成覆盖基因治疗、细胞治疗、脑科学、合成生物和高端生物医用材料的产业生态,吸引多家领先企业入驻,助力首都生命健康产业高质量发展。

媒体报道
洞见 I 中国创新药,下一个10年怎么投? 医药魔方
创新药板块强势表现吸引市场关注,恒生创新药ETF(520500)连续六周获资金净流入 新浪科技
北京市明确未来产业新航向 中国药谷布局5大赛道引领生命健康产业高质量发展 医药魔方
年销8亿的抗精神药,国内已有4家仿制获批 医药魔方
26家创新药公司完成新一轮融资! 医药魔方
31家药企厮杀18亿畅销药!第十一批国采110+品种达入场线... 医药魔方
11款抗肿瘤新药有望第二季度获批上市 医药魔方

事件追踪
2025-01-14 北京:重点培育人形机器人、商业航天、生物制造、新材料等20个未来产业
2025-01-09 北京力推脑机接口创新,2030年或实现多领域规模化商用
2025-01-09 北京出台《加快脑机接口创新发展行动方案(2025-2030年)》
2024-05-23 北京:到2026年 医药健康产业总规模达到1.25万亿元
2023-06-28 北京市政府办公厅印发《北京市机器人产业创新发展行动方案(2023—2025年)》

#热门话题

BY Readhub


Warning: Undefined variable $i in /var/www/tg-me/post.php on line 283

Share with your friend now:
tg-me.com/readhub_cn/252895

View MORE
Open in Telegram


Readhub Telegram | DID YOU KNOW?

Date: |

At a time when the Indian stock market is peaking and has rallied immensely compared to global markets, there are companies that have not performed in the last 10 years. These are definitely a minor portion of the market considering there are hundreds of stocks that have turned multibagger since 2020. What went wrong with these stocks? Reasons vary from corporate governance, sectoral weakness, company specific and so on. But the more important question is, are these stocks worth buying?

Should You Buy Bitcoin?

In general, many financial experts support their clients’ desire to buy cryptocurrency, but they don’t recommend it unless clients express interest. “The biggest concern for us is if someone wants to invest in crypto and the investment they choose doesn’t do well, and then all of a sudden they can’t send their kids to college,” says Ian Harvey, a certified financial planner (CFP) in New York City. “Then it wasn’t worth the risk.” The speculative nature of cryptocurrency leads some planners to recommend it for clients’ “side” investments. “Some call it a Vegas account,” says Scott Hammel, a CFP in Dallas. “Let’s keep this away from our real long-term perspective, make sure it doesn’t become too large a portion of your portfolio.” In a very real sense, Bitcoin is like a single stock, and advisors wouldn’t recommend putting a sizable part of your portfolio into any one company. At most, planners suggest putting no more than 1% to 10% into Bitcoin if you’re passionate about it. “If it was one stock, you would never allocate any significant portion of your portfolio to it,” Hammel says.

Readhub from in


Telegram Readhub
FROM USA